Ophthalmic device development
The company is developing the Optejet® device for use with its own drug-device therapeutic product candidates.
Source: LinkedIn company description · Retrieved October 13, 2026
Eyenovia is an ophthalmic technology company developing the Optejet® device.
The device is intended for use with the company’s drug-device therapeutic product candidates for presbyopia and pediatric progressive myopia.
Based on the company’s public LinkedIn information, supplied through RevenueBase.
The company is developing the Optejet® device for use with its own drug-device therapeutic product candidates.
Source: LinkedIn company description · Retrieved October 13, 2026
The device is also intended for out-licensing for additional indications.
Source: LinkedIn company description · Retrieved October 13, 2026
Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.
Positions describe ordering within each source list. See how lists are built ↗
Embeddable award for your website
RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 14, 2026, September 18, 2026, September 19, 2026, September 21, 2026, September 28, 2026, September 29, 2026, October 9, 2026 and October 10, 2026. How the company lists are built.
Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.
Explore more companies by name, headquarters and business focus.